Gu et al. showed in chronic myeloid leukaemia, TIC were suppressed by the herbal drug berbamine and docking of berbamine traced it to CAMK2G, but no details of the mediating pathway were provided16. Here, CAMK2G is linked to chronic myelogenous leukemia, BCR-ABL1 positive.